Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes

Syringaresinol-4-O-β-d-glucoside (SSG), a furofuran-type lignan, was found to modulate lipid and glucose metabolism through an activity screen of lipid accumulation and glucose consumption, and was therefore considered as a promising candidate for the prevention and treatment of metabolic disorder,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Pharm Sin B
Main Authors: Wang, Shuai, Wu, Chongming, Li, Xin, Zhou, Yue, Zhang, Quanyang, Ma, Fuchao, Wei, Jianhe, Zhang, Xiaopo, Guo, Peng
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518665/
https://ncbi.nlm.nih.gov/pubmed/28752030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2017.04.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados